CAS 16198-01-9: 2H-1-Benzopyran-3,5,7-triol,2-[3,4-bis(acetyloxy)phenyl]-3,4-dihydro-, 3,5,7-triacetate, (2R,3S)-

(+)-Catechin pentaacetate (Catechin pentaacetate) is an esterified derivative of catechin, which reduces iron and zinc transport proteins in the duodenum.

Catechin pentaacetate is a chemically modified derivative of catechin, which is a polyphenolic compound naturally found in various plant sources, such as tea leaves and certain fruits. The modification involves acetylation of the hydroxyl groups on the catechin molecule, resulting in catechin pentaacetate. This alteration impacts its physicochemical properties and potentially affects its bioavailability and biological activity. Catechin pentaacetate acts through its interactions with cellular pathways, potentially influencing oxidative stress and modulating enzyme activities due to its polyphenolic structure. Its acetylated form may enhance cellular uptake or stability, allowing for varied biological interactions compared to its parent compound. This product is primarily used in scientific research to investigate its effects on biological systems and its potential therapeutic applications. Researchers explore its role in modulating oxidative stress pathways and its possible influence on inflammation and cell signaling cascades. Its applications may extend to preclinical models aiming to better understand the implications of polyphenolic derivatives in health and disease.